Products

Lumea Viewer+
Lumea
Clinical Decision Support & Reference
Lumea Viewer+ is an FDA-cleared digital pathology viewer and diagnostic hub for pathologists, offering AI integration, lightning-fast image rendering, and comprehensive case management within a unified workflow.
Viewer+
Lumea
Clinical Decision Support & Reference
Lumea's Viewer+ is an FDA-cleared digital pathology viewer with AI-driven workflows for primary diagnosis in clinical settings, supporting various specialties.

See all 2 products →

About Lumea

Lumea is a leading healthcare AI company specializing in digital pathology solutions designed to enhance the efficiency, quality, and accessibility of cancer diagnostics. Their comprehensive platform integrates advanced tissue-handling technology with best-in-class digital viewers and AI-driven workflows. This approach allows pathologists to transition from traditional microscopy to a fully digital environment, streamlining processes from specimen preparation to final diagnosis. Lumea’s technology is particularly impactful in improving sample quality, accelerating turnaround times, and boosting cancer detection rates, while simultaneously reducing costs and operational complexities for laboratories and clinics.

The company is recognized as the U.S. leader in primary clinical digital pathology, processing the highest volume of digital diagnoses nationwide. Lumea’s solutions are trusted by top urology, gastroenterology, and dermatology groups, optimizing tissue integrity and delivering measurable returns on investment. Their AI tools, such as the Vision-Language Model HistoGPT, are designed to assist in automating complex clinical documentation by drafting pathology reports, thereby improving efficiency and consistency in patient care, especially in high-demand environments. Lumea’s commitment is to transform pathology for a more precise and efficient future, with a global presence spanning five continents.

Focus Areas

Digital pathology AI-driven workflows cancer diagnostics urology dermatopathology gastroenterology tissue-handling technology image management systems (IMS) laboratory information systems (LIS) molecular testing integration virtual reality in pathology

Business Intelligence

Key InvestorsMichael O. Leavitt (Board Chairman)
PartnershipsAIxMed, elea, Primaa, ZayaAI, Valar Labs, Paige, Verily (Google Health), Tempus, Voicebrook, Cleveland Diagnostics
TechnologyDigital Diagnostic Operating System (DxOS), full-stack solution, pre-analytical innovations (BxBoards®, BxChip®), IMS Viewer+, AI-native LIS, cloud-native, scanner agnostic, virtual reality viewer
FDA ClearancesAt least one (digital pathology platform/IMS Viewer+) cleared products (estimated)

What Physicians Need to Know

Digital Pathology Leadership
Lumea is recognized as the U.S. leader in primary clinical digital pathology, processing the highest volume of digital cases nationwide with an FDA-cleared diagnostic platform.
AI-Driven Workflows
They offer integrated AI-powered workflows and access to an open AI marketplace, enhancing diagnostic efficiency, accuracy, and accessibility in cancer care. Lumea partners with leaders like Paige to embed advanced AI applications.
Comprehensive Cancer Diagnostics
Lumea specializes in improving cancer diagnosis across various specialties, including significant adoption in urology (supporting over half the U.S. market), dermatopathology, and gastroenterology.
Innovative Tissue-Handling Technology
Proprietary tissue-handling technologies like BxBoardsu00ae and BxChipu00ae improve sample quality, preserve tissue orientation and integrity, speed up turnaround times, and increase cancer detection rates.
Integrated Image Management Systems (IMS)
Their Viewer+ is a fully-loaded IMS that integrates seamlessly with any LIS, providing comprehensive infrastructure for digital pathology, including slide storage, visualization, annotations, and AI outputs.
Advanced Laboratory Information Systems (LIS)
Lumea offers BxLinku2122, an all-in-one digital pathology-enabled LIS that combines LIS functionality with a robust digital pathology suite for streamlined operations, billing, and reporting.
Molecular Testing Integration
The platform enables one-click and simplified molecular test ordering, which can significantly improve testing yield and reduce turnaround times for critical results.
Physician Tip

For physicians, Lumea stands out by offering an end-to-end, 'full-stack' digital pathology solution that aims to revolutionize workflow efficiency, diagnostic accuracy, and patient care. Expect faster diagnoses and second opinions due to immediate digital slide access and streamlined processes. The integration of AI tools acts as an 'extra set of eyes' for quality control and can automate tedious tasks, freeing up pathologists for more complex analysis. Their innovative tissue-handling technology means better quality samples from the start, leading to more reliable diagnoses and potentially higher cancer detection rates. The flexibility to work remotely and access cases from anywhere enhances work-life balance and collaboration with colleagues globally. Lumea's platform is designed to reduce fragmentation by unifying LIS, IMS, and AI tools, making it a comprehensive solution for modern pathology practices.

Lumea provides robust integration capabilities. Their Viewer+ IMS is designed to integrate seamlessly with existing Laboratory Information Systems (LIS), allowing practices to leverage digital pathology without replacing their core LIS. For those seeking a complete overhaul, their BxLinku2122 offers an all-in-one LIS and digital pathology suite. Furthermore, Lumea features an open AI marketplace, facilitating the integration of third-party diagnostic AI algorithms and fostering collaboration with leading AI companies like Paige.

Products by Lumea

2 products in the directory

Lumea Viewer+
Lumea
Clinical Decision Support & Reference
Lumea Viewer+ is an FDA-cleared digital pathology viewer and diagnostic hub for pathologists, offering AI integration, lightning-fast image rendering, and comprehensive case management within a unified workflow.
Viewer+
Lumea
Clinical Decision Support & Reference
Lumea's Viewer+ is an FDA-cleared digital pathology viewer with AI-driven workflows for primary diagnosis in clinical settings, supporting various specialties.

What the Web Says

Lumea appears to be a brand name used by different companies, primarily Philips for IPL hair removal devices and Luma Health for healthcare IT solutions. There's also a staffing company called Lumea Staffing. Reviews for the Philips Lumea IPL devices are generally positive, highlighting their effectiveness in hair reduction. Luma Health, a healthcare IT company, receives positive feedback for its patient communication and support. Lumea Staffing has mixed reviews, with some positive experiences regarding job placement and others citing issues with pay and benefits.

Overall: Mixed

Strengths

  • Philips Lumea IPL is effective for hair reduction and can lead to long-lasting results.
  • Philips Lumea IPL is easy to use and comfortable for many users.
  • Luma Health offers easy and quick secure messaging for patient communication.
  • Luma Health has excellent customer support and is intuitive to use.
  • Lumea (digital pathology) has a positive company culture and leadership.
  • Lumea (digital pathology) employees are satisfied with compensation and teamwork.

Limitations

  • Philips Lumea IPL may not be permanent and requires consistent use for maintenance.
  • Some Philips Lumea IPL users experienced battery issues or device malfunction.
  • Philips Lumea IPL may be painful for some users, especially in sensitive areas.
  • Luma Health can be challenging for older patients to use.
  • Luma Health's secure messages only stay active for seven days.
  • Lumea Staffing has received negative feedback regarding pay and benefits.

Based on reviews from: Comparably, Indeed.com, Reddit, ProductReview.com.au, YouTube, G2, Capterra

Last updated: 2026-07-25

Videos

News, demos, and interviews about Lumea.

Loading videos...

Videos load interactively. If none appear, search YouTube for Lumea →

View all on YouTube

Press & Coverage

Lumea Digital Pathology
Lumea Named Best New Biopsy Technology Solution in 2026 MedTech Breakthrough Awards
Lumea was recognized as the winner of the u201cBest New Biopsy Technology Solutionu201d award in the 2026 MedTech Breakthrough Awards program, highlighting its innovative tissue-handling technology designed to improve specimen integrity.
2026-05
Lumea Digital Pathology
Lumea Appoints Former HHS Secretary Michael O. Leavitt as Board Chairman; Strategic Funding and 40% Market Share Signal High-Growth Phase
Lumea announced the appointment of Michael O. Leavitt, former HHS Secretary, as Board Chairman, alongside strategic funding and a significant market share, indicating a high-growth phase for the company.
2026-04
Lumea Digital Pathology
Lumea and elea Launch a Unified Pathology Ecosystem, Merging Best-in-Class IMS with AI-Native LIS
Lumea and elea partnered to create a unified pathology ecosystem, combining Lumea's IMS with elea's AI-native LIS to streamline workflows and boost efficiency for pathologists.
2026-03
Lumea Digital Pathology
Lumea Partners with Primaa to Expand Dermatopathology Offerings with Cleo Skin AI
Lumea partnered with Primaa to integrate Cleo Skin AI into its IMS Viewer+, expanding dermatopathology offerings and enhancing digital workflows for dermpaths.
2026-03
Lumea Digital Pathology
Lumea Receives Global Recognition Award for Exceptional Achievement
Lumea received a Global Recognition Award for exceptional achievement, acknowledging its contributions to cancer diagnostics through advanced technological solutions and impact on worldwide medical outcomes.
2026-06
EIN Presswire
Lumea Announces Collaboration with Cleveland Diagnostics to Enable Greater Access to IsoPSAu00ae Testing
Lumea collaborated with Cleveland Diagnostics to increase access to IsoPSAu00ae testing for prostate cancer risk stratification.
2025-12
EIN Presswire
Lumea and Valar Labs Announce Partnership to Improve Bladder Cancer Treatment Decisions
Lumea and Valar Labs partnered to integrate Valar Labs' Vesta tests into the Lumea digital pathology platform, aiming to improve bladder cancer treatment decisions.
2025-10
Pathology Times
Lumea Honored with Four Major Awards for Innovation and Growth in Digital Pathology
Lumea received four prestigious awards, including the Inc. 5000 list, Utah Business Fast 50, a 2025 Global Recognition Award, and a Utah Best of State award, recognizing its rapid growth and impact on cancer diagnostics.
2025-08

Frequently Asked Questions

Lumea offers an FDA-cleared digital pathology platform, including the Viewer+ IMS and BxLink LIS, designed to integrate diagnostic tools and an open AI marketplace. They partner with companies like Paige and Mindpeak to embed AI-assisted diagnostic and biomarker applications, enhancing precision in cancer diagnostics across various specialties.
Lumea's platform supports over half of the U.S. urology market and top dermatology and gastroenterology groups, optimizing tissue integrity and boosting detection rates. Their patented tissue-handling technologies, such as BxBoard and BxChip, improve specimen quality, preserve anatomic orientation, and increase cancer detection rates from the point of biopsy through lab processing.
Lumea provides the Viewer+ IMS and the comprehensive BxLink LIS, which is an all-in-one digital pathology-enabled LIS. These systems are designed for seamless integration with existing lab infrastructure, offering features like RFID specimen tracking, paperless requisitions, and automated reporting to optimize the entire pathology workflow from grossing to sign-out.
Lumea's digital pathology platform is designed to embed molecular testing directly into the workflow, enabling faster ordering, processing, and return of results. Their Viewer+u2122 integrated workflow allows for conditional ordering of molecular tests, reducing turnaround times and supporting precision medicine.
Lumea's platform, including Viewer+u2122, is FDA-cleared and has achieved CE marking under IVDR for clinical use in Europe, demonstrating global regulatory compliance. They implement robust security measures, including modern encryption and authentication, to protect patient data in accordance with regulations like HIPAA and HITECH.
Lumea is a U.S. leader in primary clinical digital pathology, processing the highest volume of digital cases nationwide, and is experiencing significant growth. They offer consulting services for implementation and have strategic partnerships with companies like Paige, Mindpeak, Mopec, Voicebrook, elea, ZayaAI, and OptraSCAN to enhance AI, grossing, reporting, and scanning solutions.
Yes, Lumea has demonstrated a virtual reality viewer that allows pathologists to navigate slides, annotate, open reports, and preview PDFs using a headset and hand gestures, without a mouse or monitor. This immersive, hands-free workflow explores potential for efficiency and accessibility in pathology review.

Related Companies

Precision Medical Ventures, Inc. Dba Revealdx (RevealDx) is a Seattle-based healthcare AI company focused on dramatically improving lung cancer outcomes through non-invasive diagnosis. They develop advanced, radiomics and AI-enabled, lung cancer decision support software. Their flagship product, RevealAI-Lung, is a Computer-Assisted Diagnostic (CADx) software that analyzes patient lung computed tomography (CT) images to provide information […]

SafeBeat Rx is a healthcare AI company focused on transforming cardiac care by expanding access to remote patient monitoring (RPM), continuous telemetry, event monitoring, and software-enabled remote therapeutic monitoring (RTM). The company’s core offering is an integrated technology that utilizes automated artificial intelligence-based software to analyze electrocardiogram (ECG) data. This technology is designed to replace […]

Measure Labs, Inc., operating as PreemptiveAI, Inc., is a healthcare AI company focused on transforming healthcare from reactive disease management to proactive risk identification and prevention. The company has developed a “revolutionary” foundation model, a large-scale machine learning model, that interprets biomedical signals from smartphones and wearable devices to predict health outcomes in real-time. This […]

EarliPoint Health, formerly EarliTec Diagnostics, is a healthcare AI company dedicated to transforming autism care through innovative, FDA-cleared eye-tracking technology. The company’s core product, the EarliPoint System, is a medical device designed to aid qualified clinicians in the diagnosis and assessment of Autism Spectrum Disorder (ASD) in children aged 16 months through 95 months (7 […]

Onera B.V., operating as Onera Health, is a Dutch med-tech company that is transforming sleep diagnostics and monitoring with its innovative, self-applied, no-wire polysomnography (PSG) solution. [12, 19] Founded as a spin-off from the imec research center, a leader in nanoelectronics and digital technologies, Onera aims to make clinical-grade sleep studies broadly accessible, convenient, and […]

Digestaid – Artificial Intelligence Development SA is a healthcare AI company focused on developing advanced deep learning solutions for the detection of digestive lesions. The company aims to revolutionize gastrointestinal practice by applying AI technologies across digestive and pancreatobiliary tracts, as well as functional tests. Their solutions are designed to overcome diagnostic limitations of current […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.